Search results
Results from the WOW.Com Content Network
Female fertility agents are medications that improve female’s ability to conceive pregnancy. These agents are prescribed for infertile female who fails to conceive pregnancy after 1-year of regular and unprotected sexual intercourse. [1] The following will cover the advancements of female fertility agents, major causes of female infertility.
Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer. [ 1 ] It was patented in 1986 and approved for medical use in 1996. [ 4 ]
Ovarian stimulation with the aromatase inhibitor letrozole has been proposed for ovulation induction in order to treat unexplained female infertility. In a multi-center study funded by the National Institute of Child Health and Development, ovarian stimulation with letrozole resulted in a significantly lower frequency of multiple gestation (i.e., twins or triplets) but also a lower frequency ...
Aromatase inhibitors are a common fertility treatment to treat women with PCOS. A meta-analysis analyzing live birth rates for women with PCOS treated with clomiphene compared to letrozole found that letrozole resulted in higher live birth rates. [11] However, ovulation induction remains an off-label indication, which affects use.
In this episode of In Conversation, we look at some of the most important information everyone should have about perimenopause and menopause with our special guest, Dr. Kate Clancy, from the ...
Image credits: Old-time Photos "That's why funny, unexpected and random events in old photos always seem so much more magical to me," Ed continued. "The odds of capturing that moment were ...
A woman who stowed away on a Delta flight from New York to Paris last week has been released from custody after being charged in federal court, but with more than a dozen conditions.
[18] [19] [20] When used in fertility treatment they can also be associated with abdominal pain and ovarian hyperstimulation. [ 18 ] [ 20 ] Subcutaneously administered agents are also associated with injection-site reactions [ 19 ] [ 21 ] and abarelix (neither of these being GnRH agonists, but instead being antagonists) has been linked with ...